Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness Read More > October 14, 2020
The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD Read More > October 14, 2020
The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence Read More > October 11, 2020
Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans Read More > October 8, 2020
Polypharmacology or “Pharmacological Promiscuity” In Psychedelic Research: What Are We Missing? Read More > October 6, 2020
Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review Read More > October 5, 2020
The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain Read More > October 2, 2020
The emerging role of psilocybin and MDMA in the treatment of mental illness Read More > September 30, 2020
Biosynthesis, total synthesis, and biological profiles of Ergot alkaloids Read More > September 30, 2020
